Story perspectives

New Research Reveals Chemotherapy's Hidden Neurological Dangers

10/31/2025

Summary

Story summary

Researchers at Wake Forest University and Weill Cornell Medicine reported in Science Translational Medicine that the IRE1? pathway in immune cells drives nerve damage in chemotherapy patients, with higher activation linked to severe neuropathy.
Blocking the IRE1? pathway could prevent nerve pain and improve treatment adherence.
A separate study indicates chemotherapy may disrupt the brain's lymphatic system, contributing to chemo brain.
Both studies emphasize neurological side effects in cancer treatment.

1 of 1

Story summary

Researchers at Wake Forest University and Weill Cornell Medicine reported in Science Translational Medicine that the IRE1? pathway in immune cells drives nerve damage in chemotherapy patients, with higher activation linked to severe neuropathy.
Blocking the IRE1? pathway could prevent nerve pain and improve treatment adherence.
A separate study indicates chemotherapy may disrupt the brain's lymphatic system, contributing to chemo brain.
Both studies emphasize neurological side effects in cancer treatment.